STOCK TITAN

Bio Green Med (NASDAQ: BGMS) declares preferred dividend for holders

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Bio Green Med Solution, Inc. reported that its Board of Directors declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock. The dividend will be paid on November 1, 2025 to holders of the Preferred Stock who are on record as of the close of business on October 20, 2025.

Positive

  • None.

Negative

  • None.
false 0001130166 0001130166 2025-10-07 2025-10-07 0001130166 BGMS:CommonStockParValue0.001PerShareMember 2025-10-07 2025-10-07 0001130166 BGMS:PreferredStock0.001ParValueMember 2025-10-07 2025-10-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

October 7, 2025

Date of Report (date of earliest event reported)

 

 

Bio Green Med Solution, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware   0-50626   91-1707622

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

Level 10, Tower 11, Avenue 5, No. 8

Jalan Kerinchi, Kuala Lumpur, Malaysia 59200

(Address of principal executive offices) (Zip code)

 

(908) 517-7330

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   BGMS   The Nasdaq Capital Market
Preferred Stock, $0.001 par value   BGMSP   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01 Other Events.

 

On October 7, 2025, the Board of Directors of Bio Green Med Solution, Inc. (the “Company”) declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock (the “Preferred Stock”). The dividend is payable on November 1, 2025, to Preferred Stock stockholders of record as of the close of business on October 20, 2025.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: October 7, 2025 Bio Green Med Solution, Inc.
     
  By: /s/ Datuk Dr. Doris Wong Sing Ee
  Name: Datuk Dr. Doris Wong Sing Ee
  Title: Chief Executive Officer and Executive Director

 

 

FAQ

What dividend did Bio Green Med Solution (BGMS) announce?

Bio Green Med Solution declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock.

Which Bio Green Med (BGMS) security receives the new dividend?

The dividend applies to Bio Green Med Solution’s 6% Convertible Exchangeable Preferred Stock, which is listed as Preferred Stock with a par value of $0.001 per share.

When is the record date for Bio Green Med’s preferred dividend?

The record date for the dividend is October 20, 2025, meaning holders of the Preferred Stock at the close of business on that date will be entitled to receive the payment.

When will Bio Green Med (BGMS) pay the preferred stock dividend?

The quarterly cash dividend on the Preferred Stock is scheduled to be paid on November 1, 2025.

Does the dividend affect Bio Green Med’s common stock?

The disclosed dividend relates specifically to the 6% Convertible Exchangeable Preferred Stock. The disclosure does not state any dividend for the common stock.

Who approved the Bio Green Med preferred dividend?

The quarterly cash dividend on the Preferred Stock was declared by the Board of Directors of Bio Green Med Solution, Inc. on October 7, 2025.

Bio Green Med Solution Inc

NASDAQ:BGMS

BGMS Rankings

BGMS Latest News

BGMS Latest SEC Filings

BGMS Stock Data

7.01M
1.57M
Pharmaceutical Preparations
BERKELEY HEIGHTS